AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Exploring Biospecific Antibodies and Treatment Options in Challenging Cases
This chapter covers the safety and effectiveness of biospecific antibodies in dialysis patients, highlighting recent studies that alleviate concerns over neurotoxicity. It also examines treatment alternatives for patients unable to tolerate maintenance therapy, focusing on proteasome inhibitors and monoclonal antibodies.